[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581731":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":32,"locations":38,"responsibleParty":94,"collaborators":97,"id":102,"slug":103,"hasResults":104,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":10,"eligibilityCriteria":108,"healthyVolunteers":104,"sex":109,"minAge":110,"maxAge":10,"enrollmentInfo":111,"targetDuration":10,"studyType":114,"phases":10,"briefSummary":115,"conditions":116,"keywords":119,"overallStatus":61,"whyStopped":10,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":131},{"fullName":5,"class":6},"University of Auckland, New Zealand","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment",null,"Patients undergoing Body Surface Gastric Mapping before and after administration of prescribed prokinetic\u002Fneuromodulator",[13],"Device: Gastric Alimetry",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Gastric Alimetry","The Gastric Alimetry™ System is intended to record, store, view and process gastric myoelectrical activity as an aid in the diagnosis of various gastric disorders.",[9],[21,25,28,30],{"name":22,"affiliation":23,"role":24},"Henry Parkman, MD","Temple University","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":27,"role":24},"Vincent Ho, MBBS, FRACP, FACP, PhD","University of Western Sydney",{"name":29,"affiliation":5,"role":24},"Charlotte Daker, MD",{"name":31,"affiliation":5,"role":24},"Greg O'Grady, MD, PhD",[33],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Genevieve M Johnston, PhD","CONTACT","+64 9 373 7599","gen.johnston@auckland.ac.nz",[39,59,78],{"facility":23,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"NOT_YET_RECRUITING","Philadelphia","Pennsylvania","19122","United States","US",{"type":47,"coordinates":48},"Point",[49,50],-75.16362,39.95238,{"lat":50,"lon":49},[53,57],{"name":54,"role":35,"phone":55,"phoneExt":10,"email":56},"Henry Parkman, PhD\u002FMD","800-836-7536","henry.parkman@temple.edu",{"name":58,"role":24,"phone":10,"phoneExt":10,"email":10},"Henry Parkman, MD, PhD",{"facility":60,"status":61,"city":62,"state":63,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Western Sydney University","RECRUITING","Sydney","New South Wales","2560","Australia","AU",{"type":47,"coordinates":68},[69,70],151.20732,-33.86785,{"lat":70,"lon":69},[73,77],{"name":74,"role":35,"phone":75,"phoneExt":10,"email":76},"Madhuri Venigalla, PhD","+61 2 4634 4579","madhuri.venigalla@alimetry.com",{"name":26,"role":24,"phone":10,"phoneExt":10,"email":10},{"facility":79,"status":61,"city":80,"state":80,"zip":81,"country":82,"countryCode":83,"cosmosGeoPoint":84,"geoPoint":88,"contacts":89},"Te Whatu Ora Waitemata","Auckland","0622","New Zealand","NZ",{"type":47,"coordinates":85},[86,87],174.76349,-36.84853,{"lat":87,"lon":86},[90,93],{"name":29,"role":35,"phone":91,"phoneExt":10,"email":92},"+64 21 349 305","Charlotte.Daker@waitematadhb.govt.nz",{"name":29,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":24,"investigatorFullName":95,"investigatorTitle":96,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Greg O'Grady","MD\u002FPhD",[98,99,100],{"name":27,"class":6},{"name":23,"class":6},{"name":101,"class":6},"North Shore Hospital, New Zealand","100581731","prokinetics-and-body-surface-gastric-mapping-in-dyspeptic-patients-baseline-and-treatment-effects-100581731",false,"NCT06854120","Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects","Body Surface Gastric Mapping in Patients With Dyspeptic Symptoms: Recordings at Baseline and on Medical Therapy","Inclusion Criteria:\n\n* Patients 18 years of age and older\n* Diagnosis of gastroparesis and\u002For functional dyspepsia\n* Being prescribed a prokinetic agent or symptom modulator for their clinical care\n* Able to undergo BSGM recording both before and during treatment\n* Able to give informed consent for undergoing a baseline BSGM recording and an additional recording while on treatment\n\nExclusion Criteria:\n\n* Under 18 years of age\n* Prior surgery on esophagus, stomach (appendectomy and cholecystectomy are allowed)\n* History of skin allergies or a history of extreme sensitivity to cosmetics or lotions\n* Pregnant women\n* No vulnerable groups such as prisoners, individuals with known cognitive impairment, or institutionalized individuals be involved","ALL","18 Years",{"count":112,"type":113},125,"ESTIMATED","OBSERVATIONAL","Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with gastric emptying tests, although the correlation with symptoms is weak. Prokinetic agents (e.g., metoclopramide, erythromycin) and symptom modulators (e.g., nortriptyline, mirtazapine) are commonly used, but selecting the right medication can be difficult, as it's often based on symptoms rather than the underlying gastric issues. Body Surface Gastric Mapping (BSGM) using the Gastric Alimetry device is a novel, non-invasive tool to assess gastric myoelectrical activity and symptoms. This study aims to perform two BSGM recordings-one before and one after medical therapy-to understand how medications affect gastric function and identify baseline BSGM factors that could predict responses to treatment, potentially guiding tailored therapies based on individual gastric dysfunction.",[117,118],"Gastroparesis","Functional Dyspepsia",[117,118,120,121],"Gastric Motility","Body Surface Gastric Mapping","2026-06-08",{"date":124,"type":125},"2026-06-11","ACTUAL",{"date":127,"type":125},"2025-02-26",{"date":129,"type":113},"2028-08-26",{"name":5,"class":6},3]